News

Allos Therapeutics, a biopharmaceutical company, has reported that the European Medicines Agency, with a positive opinion of the Committee for Orphan Medicinal Products, has granted orphan medicinal product

The two centers generate approximately $5.6 million in annual revenues. One center is exclusively magnetic resonance imaging (MRI) while the other is a multi-modality facility. The acquisition is

BioNanomatrix, a developer of nanoscale platforms for biomedical research, molecular diagnostics and personalized medicine, has received a Phase II grant from the National Human Genome Research Institute of

Under the terms of the agreement, Lipoxen will provide Glide Pharma with SuliXen which Glide Pharma will then incorporate into its proprietary Glide SDI, needle-free, drug delivery technology

Cortex will focus its efforts on the development of its clinical programs involving CX717 and CX1739, which it believes will have the greatest opportunity for creation of shareholder

Synta Pharmaceuticals, a developer and marketer of small molecule drugs, has treated the first patient in a Phase I/II clinical study of STA-9090, a novel heat shock protein

Oxygen Biotherapeutics, a developer of biotechnology products, has announced that the company will move ahead with a line of gels based on Oxycyte. The first and most basic

US-based UnitedHealthcare’s Golden Rule Insurance Company has introduced new coverage options to reportedly help make dental and vision care more affordable for consumers in 15 states and the

Perrigo Company, a healthcare supplier, has reported that its partner Cobrek Pharmaceuticals has filed an abbreviated new drug application for clindamycin phosphate foam 1%, a generic version of